| Aim is to prompt prioritisation of treatment for serious and common diseases Related items from OnMedica NICE’s cost-effectiveness system is harming patients, claim experts First malaria vaccine for children could be recommended for use by autumn Pharmaceutical industry regulation undermines NICE drugs appraisal work TB drug resistance is growing around the world Cancer Drugs Fund axes 25 treatments from list |
Friday 8 May 2015
Range of new and costly drugs added to WHO ‘essentials’ list
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment